3 rezultatima
BACKGROUND
Spinal muscular atrophy is a common neurologic disorder of infants and children with a high mortality rate. Clinical trials have not been attempted in this population until recently.
OBJECTIVE
To demonstrate that 4 outcome measures are reliable for use in clinical trials in patients with
OBJECTIVE
The aim of this article was to determine reliability of the Test of Infant Motor Performance (TIMP) in infants with spinal muscular atrophy, type I (SMA-I).
METHODS
Interrater reliability training was undertaken by 17 physical therapist evaluators using 6 infants with hypotonia and
Sixty-five subjects with Down's syndrome were followed up and retested 2 years after the initial recording of auditory P300 (P3) event-related potential described in a companion paper (Blackwood et al., 1988). The number of subjects showing clinical evidence for Alzheimer's type dementia had